Learn more

SIRTEX MEDICAL LTD

Overview
  • Total Patents
    77
  • GoodIP Patent Rank
    44,614
  • Filing trend
    0.0%
About

SIRTEX MEDICAL LTD has a total of 77 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1994. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are FERX INC, SOOFT ITALIA S P A and ADVANCED NEUROREGENERATIVE THERAPIES LLC.

Patent filings per year

Chart showing SIRTEX MEDICAL LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gray Bruce Nathaniel 37
#2 Cade David 16
#3 Ruys Andrew John 10
#4 Tapner Michael 9
#5 Jones Stephen Keith 8
#6 Wong Gilman 6
#7 Van Den Berg Brendon 6
#8 David Cade 4
#9 Rutherford Katrina Francis 4
#10 Amthauer Holger 3

Latest patents

Publication Filing date Title
AU2017100081A4 An Administering Device for Administering a Therapeutic Substance
AU2016203299A1 Polymer Based Radionuclide Containing Particulate Material
AU2015327748A1 A transferring device for transferring a toxic substance
WO2016049685A1 An administering device for administering a therapeutic substance
US2016008497A1 Method for treating lung carcinoma
US2017151357A1 Method for treating renal cell carcinoma
CN106102735A Neoplastic treatment
AU2014203772A1 Method for Treating Lung Carcinoma
CA2856389A1 Method for treating lung carcinoma
AU2013202610A1 Polymer Based Radionuclide Containing Particulate Material
AU2007202491A1 Polymer Based Radionuclide Containing Particulate Material
WO2006002488A1 Combination therapy for treatment of neoplasia
AU2003903387A0 Combination therapy for treatment of neoplasia
CA2427258A1 Combination therapy for treatment of neoplasia
AU2003203953A1 Combination Therapy for Treatment of Neoplasia
AU2003900335A0 Microparticles for selectively targeted hyperthermia
EP3031472A1 Polymer based radionuclide containing particulate material
AUPR848701A0 Radionuclide containing particulate material
AUPR818401A0 Combined use of use of radioactive particulate meterial together with chemotherapy and/or immunotherapy and/or anti-angiogenesis therapy
AUPR098200A0 Production of low density radionuclide containing microspheres